Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy

SUMMARY: The use of buffered soluble alendronate 70 mg effervescent tablet, a convenient dosing regimen for bisphosphonate therapy, seems a cost-effective strategy compared with relevant alternative treatments for postmenopausal women with osteoporosis aged 60 years and over in Italy. INTRODUCTION:...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiligsmann, M., Maggi, S., Veronese, N., Sartori, L., Reginster, J.-Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929941/
https://www.ncbi.nlm.nih.gov/pubmed/33443610
http://dx.doi.org/10.1007/s00198-020-05802-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929941/
https://www.ncbi.nlm.nih.gov/pubmed/33443610
http://dx.doi.org/10.1007/s00198-020-05802-5

Ejemplares similares